Venture Capital Investors

Harris & Harris Group

VC investing group Harris & Harris Group backs innovative technology companies.

Venture Investor Overview

Venture Investor
Harris & Harris Group
Status
InActive
Investor Type
Venture Capital
Activity Level
74 transactions
Funds Raised
Unknown
Industry Focus
Medical Devices & Instruments

Contact Information

Contact
Douglas Jamison
Title
Chief Executive Officer
Mailing Address
530 Lytton Ave. 2nd Floor
Palo Alto, CA 94301
USA
Phone
(650) 617-3386
Website
www.hhvc.com
Email Address
[email protected]

Background Information

Overview
Harris & Harris Group, Inc. is a publicly held venture capital company (NASDAQ symbol: TINY). The Company operates as a Business Development Company (BDC) under the Investment Company Act of 1940.
Profile
Harris & Harris Group LinkedIn Company Profile
Social Media
Harris & Harris Group Company Twitter Account
Company News
Harris & Harris Group News
Facebook
Harris & Harris Group on Facebook
YouTube
Harris & Harris Group on YouTube
Last Transaction
10/23/2017

Transaction History

Our records indicate that Harris & Harris Group invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
EchoPixel
10/23/2017
$8,500,000
Lodo Therapeutics
1/13/2016
$17,000,000
TARA Biosystems
1/5/2016
$2,250,000
ORIG3N
12/9/2015
$12,500,000
AgBiome
8/20/2015
$34,500,000
Nantero
6/2/2015
$31,532,926
ORIG3N
2/5/2015
$3,100,000
HzO
7/2/2014
$20,000,000
Metabolon
12/31/2013
$14,999,980
ABSMaterials
11/26/2013
$4,000,000
Enumeral Biomedical
6/30/2013
$1,520,000
AgBiome
4/12/2013
$14,500,000
Nantero
11/30/2012
$10,637,871
Mersana Therapeutics
7/31/2012
$27,000,000
OpGen
3/7/2012
$17,000,000
Senova Systems
1/13/2012
$6,700,000
BridgeLux
10/24/2011
$15,000,000
Contour Energy Systems
10/6/2011
$20,000,000
Metabolon
8/29/2011
$13,100,000
HzO
8/16/2011
$7,000,000
Produced Water Absorbents
6/28/2011
$11,000,000
Contour Energy Systems
6/22/2011
$20,000,000
Kovio
6/10/2011
$15,000,000
Cobalt Technologies
5/2/2011
$20,000,000
Sionyx
10/20/2010
$12,500,000
GEO Semiconductor
9/28/2010
$2,000,000
Laser Light Engines
9/21/2010
$13,000,000
Solazyme
8/9/2010
$52,000,000
InnovaLight
1/6/2010
$18,000,000
Cambrios Technologies
11/3/2009
$14,500,000
Metabolon
10/27/2009
$6,000,000
Adesto Technologies
9/3/2009
$14,000,000
Kovio
7/13/2009
$20,000,000
Solazyme
6/9/2009
$57,000,000
BioVex
3/30/2009
$40,000,000
TetraVitae Bioscience
12/31/2008
$6,300,100
Cobalt Technologies
10/20/2008
$25,000,000
Solazyme
8/26/2008
$45,400,000
Nextreme Thermal Solutions
8/6/2008
$13,000,000
Adesto Technologies
6/30/2008
$5,499,900
Laser Light Engines
5/28/2008
$5,000,000
BridgeLux
4/8/2008
$40,000,000
PolyRemedy
2/11/2008
$25,000,000
NanoGram
1/15/2008
$32,000,000
BioVex
11/15/2007
$13,000,000
Kovio
9/4/2007
$19,500,000
BridgeLux
8/6/2007
$23,000,000
Lifco
6/30/2007
$7,188,000
Corden Pharma - A Full-Service CDMO
6/5/2007
Unknown
Xradia
3/8/2007
$7,000,000
Sionyx
12/31/2006
$2,100,000
Sionyx
6/30/2006
$750,000
NanoOpto
6/19/2006
$5,000,000
NeoPhotonics
6/19/2006
$64,300,000
D-Wave Systems
5/16/2006
$14,000,000
BridgeLux
4/3/2006
$8,500,000
ENS Bio
3/31/2006
$5,375,000
NanoGram
1/18/2006
$18,700,000
Metabolon
1/18/2006
$8,000,000
Mersana Therapeutics
11/9/2005
$21,000,000
NanoString Technologies
11/9/2005
$40,000,000
Kereos
9/20/2005
$19,500,000
NeoPhotonics
6/30/2005
$20,000,000
Nantero
3/31/2005
$15,000,000
NanoOpto
3/22/2005
$12,000,000
Starfire Systems
3/15/2005
$500,000
Nanomix
3/4/2005
$16,000,000
Nextreme Thermal Solutions
2/8/2005
$8,000,000
Cambrios Technologies
2/1/2005
$12,000,000
Crystal IS
9/28/2004
$5,000,000
Continuum Photonics
4/6/2004
$17,500,000
NEUROMetrix
3/24/2004
$10,000,000
NeoPhotonics
3/16/2004
$40,000,000
NanoString Technologies
4/24/2003
$30,000,000

 

Investor Contacts

Title
Name
Email & Social
Partner
Alexei Andreev
  Alexei Andreev LinkedIn Profile  Alexei Andreev Twitter Account  Alexei Andreev News  Alexei Andreev on Facebook
Chief Executive Officer
Douglas Jamison
  Douglas Jamison LinkedIn Profile  Douglas Jamison Twitter Account  Douglas Jamison News  Douglas Jamison on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

Harris & Harris Group has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
ABSMaterials
Adesto Technologies
AgBiome
BioVex
BridgeLux
Cambrios Technologies
Cobalt Technologies
Continuum Photonics
Contour Energy Systems
Corden Pharma - A Full-Service CDMO
Crystal IS
D-Wave Systems
EchoPixel
ENS Bio
Enumeral Biomedical
GEO Semiconductor
HzO
InnovaLight
Kereos
Kovio
Laser Light Engines
Lifco
Lodo Therapeutics
Mersana Therapeutics
Metabolon
NanoGram
Nanomix
NanoOpto
NanoString Technologies
Nantero
NeoPhotonics
NEUROMetrix
Nextreme Thermal Solutions
OpGen
ORIG3N
PolyRemedy
Produced Water Absorbents
Senova Systems
Sionyx
Solazyme
Starfire Systems
TARA Biosystems
TetraVitae Bioscience
Xradia

 

 

 

 

Browse more venture capital investors:

Harrington Discovery Institute at University Hospitals | Harris Barton Asset Management

 

Share this article

 

About Our Venture Capital Investor Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.